Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-chloro-4-(((1r,2s)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropyl)amino)-3-methylbenzonitrile
2. Rad 140
3. Rad-140
4. Rad140
1. Rad140
2. 1182367-47-0
3. Vosilasarm
4. Rad-140
5. 4o87q44knc
6. 2-chloro-4-[[(1r,2s)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile
7. Chembl1672635
8. 2-chloro-4-(((1r,2s)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropyl)amino)-3-methylbenzonitrile
9. 2-chloro-4-((1r,2s)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropylamino)-3-methylbenzonitrile
10. Benzonitrile, 2-chloro-4-(((1r,2s)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropyl)amino)-3-methyl-
11. Vosilasarm [inn]
12. Unii-4o87q44knc
13. Vosilasarm [who-dd]
14. Testolone [nflis-drug]
15. Schembl1363683
16. Ex-a725
17. Rad140,
18. Dtxsid201032907
19. Bcp16214
20. Bdbm50336997
21. Mfcd20527233
22. S5275
23. Zinc66097792
24. Ccg-268578
25. Cs-4670
26. Db13939
27. Ncgc00485476-01
28. 2-chloro-4-({1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl}amino)-3-methylbenzonitrile
29. Ac-30220
30. Hy-14383
31. J-690050
32. Q25099854
33. 2-chloro-4-[[(1r,2s)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazole-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile
| Molecular Weight | 393.8 g/mol |
|---|---|
| Molecular Formula | C20H16ClN5O2 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 393.0992525 g/mol |
| Monoisotopic Mass | 393.0992525 g/mol |
| Topological Polar Surface Area | 119 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 623 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Vosilasarm manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vosilasarm, including repackagers and relabelers. The FDA regulates Vosilasarm manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vosilasarm API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vosilasarm manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vosilasarm supplier is an individual or a company that provides Vosilasarm active pharmaceutical ingredient (API) or Vosilasarm finished formulations upon request. The Vosilasarm suppliers may include Vosilasarm API manufacturers, exporters, distributors and traders.
click here to find a list of Vosilasarm suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Vosilasarm Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vosilasarm GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vosilasarm GMP manufacturer or Vosilasarm GMP API supplier for your needs.
A Vosilasarm CoA (Certificate of Analysis) is a formal document that attests to Vosilasarm's compliance with Vosilasarm specifications and serves as a tool for batch-level quality control.
Vosilasarm CoA mostly includes findings from lab analyses of a specific batch. For each Vosilasarm CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vosilasarm may be tested according to a variety of international standards, such as European Pharmacopoeia (Vosilasarm EP), Vosilasarm JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vosilasarm USP).
LOOKING FOR A SUPPLIER?
